|
|
Exchange: |
OTC Bulletin Board |
Security
Type: |
Common |
Shares
Out: |
149,990,000 |
Market
Cap: |
137.98(M) |
Last
Volume: |
394,168 |
Avg
Vol: |
182,850 |
52
Week Range: |
$0.9199 - $0.9199 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Lineage Cell Therapeutics is a clinical-stage biotechnology company developing cell therapies. Co. has several allogeneic cell therapy programs in development: OpRegen®, a retinal pigment epithelium cell replacement therapy for the treatment of advanced dry age-related macular degeneration with geographic atrophy; OPC1, an oligodendrocyte progenitor cell therapy for spinal cord injuries; VAC, an allogeneic cancer immunotherapy of antigen-presenting dendritic cells; and other product candidates in preclinical development covering a range of therapeutic areas and target tissues or organs. Co. has rights to HyStem, a patented biomaterial that mimics naturally occurring extracellular matrix.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
96,155 |
6,836,925 |
6,836,925 |
6,836,925 |
Total Buy Value |
$100,001 |
$7,110,902 |
$7,110,902 |
$7,110,902 |
Total People Bought |
1 |
3 |
3 |
3 |
Total Buy Transactions |
1 |
4 |
4 |
4 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
West Michael D |
Co-Chief Executive Officer |
|
2018-04-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,563 |
886,278 |
|
- |
|
Mohanty Aditya P. |
Co-Chief Executive Officer |
|
2018-04-10 |
4 |
D |
$2.49 |
$4,039 |
D/D |
(1,622) |
98,318 |
|
- |
|
Mohanty Aditya P. |
Co-Chief Executive Officer |
|
2018-04-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,688 |
99,940 |
|
- |
|
Mohanty Aditya P. |
Co-Chief Executive Officer |
|
2018-01-10 |
4 |
D |
$2.68 |
$5,513 |
D/D |
(2,057) |
95,252 |
|
- |
|
Mohanty Aditya P. |
Co-Chief Executive Officer |
|
2018-01-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,687 |
97,309 |
|
- |
|
West Michael D |
Co-Chief Executive Officer |
|
2018-01-10 |
4 |
D |
$2.68 |
$1,838 |
D/D |
(686) |
884,715 |
|
- |
|
West Michael D |
Co-Chief Executive Officer |
|
2018-01-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,562 |
885,401 |
|
- |
|
Bradsher Neal C |
Director |
|
2017-10-13 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
29,971,561 |
2.17 |
- |
|
Bradsher Neal C |
Director |
|
2017-10-13 |
4 |
B |
$2.60 |
$6,999,998 |
D/D |
2,692,307 |
29,971,561 |
3.92 |
- |
|
West Michael D |
Co-Chief Executive Officer |
|
2017-10-10 |
4 |
D |
$2.81 |
$1,652 |
D/D |
(588) |
883,839 |
|
- |
|
West Michael D |
Co-Chief Executive Officer |
|
2017-10-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,563 |
884,427 |
|
- |
|
Mohanty Aditya P. |
Co-Chief Executive Officer |
|
2017-10-10 |
4 |
D |
$2.81 |
$4,951 |
D/D |
(1,762) |
92,622 |
|
- |
|
Mohanty Aditya P. |
Co-Chief Executive Officer |
|
2017-10-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,688 |
94,384 |
|
- |
|
Skibsted Russell |
Chief Financial Officer |
|
2017-08-23 |
4 |
B |
$2.64 |
$5,285 |
D/D |
2,000 |
2,000 |
2.74 |
- |
|
Broadwood Capital Inc |
10% Owner |
|
2017-08-22 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
27,279,254 |
1.42 |
- |
|
Broadwood Capital Inc |
10% Owner |
|
2017-08-22 |
4 |
B |
$2.60 |
$25,955 |
D/D |
10,000 |
27,279,254 |
2.37 |
- |
|
West Michael D |
Co-Chief Executive Officer |
|
2017-08-22 |
4 |
B |
$2.60 |
$5,198 |
D/D |
2,000 |
882,864 |
2.81 |
- |
|
Andrews Deborah J |
Director |
|
2017-08-21 |
4 |
B |
$2.50 |
$5,990 |
D/D |
2,396 |
8,396 |
2.39 |
- |
|
Patton Stephana Eilene |
General Counsel |
|
2017-08-21 |
4 |
B |
$2.58 |
$19,376 |
D/D |
7,500 |
7,500 |
2.74 |
- |
|
Mohanty Aditya P. |
Co-Chief Executive Officer |
|
2017-08-21 |
4 |
B |
$2.50 |
$18,750 |
D/D |
7,500 |
89,696 |
2.81 |
- |
|
Kingsley Alfred D |
See Remarks |
|
2017-08-17 |
4 |
D |
$2.81 |
$843,000 |
D/D |
(300,000) |
5,481,555 |
|
- |
|
Bradsher Neal C |
Director |
|
2017-07-31 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
27,269,254 |
2.17 |
- |
|
Bradsher Neal C |
Director |
|
2017-07-31 |
4 |
B |
$2.80 |
$420,000 |
D/D |
150,000 |
27,269,254 |
3.92 |
- |
|
Kingsley Alfred D |
See Remarks |
|
2017-07-31 |
4 |
S |
$2.80 |
$420,000 |
D/D |
(150,000) |
5,781,555 |
|
- |
|
Mohanty Aditya P. |
Co-Chief Executive Officer |
|
2017-07-10 |
4 |
D |
$3.09 |
$5,445 |
D/D |
(1,762) |
82,196 |
|
- |
|
194 Records found
|
|
Page 5 of 8 |
|
|